The leading commercialization companies are rapidly adding product and service capabilities to offer a robust commercialization portfolio to life science companies
AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey
EVERSANA, the leading provider of global services to the life sciences industry, continues to use proven integrated commercialization strategies driven by cutting-edge technologies and faster, real-time data
OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders
Indegene has acquired market-access advisory Medical Marketing Economics (MME) for $10 million, as it seeks to bolster its biopharma pricing and reimbursement capabilities
Fishawack Health is a leading global commercialization partner for the modern life sciences era
The number of companies providing hub services continues to increase as they observe a growing opportunity in today’s market environment
EVERSANA™ has aggressively invested in technology, data and people to activate data-driven engagement to advance access and adherence at each stage of the product life cycle